Verrica Pharmaceuticals Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2023-11-09: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-08-08: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-05-09: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-03-06: Form 10-K; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
| 2023-08-08 | 10-Q | Emerging growth company | Yes |
| 2023-05-09 | 10-Q | Emerging growth company | Yes |
| 2023-03-06 | 10-K | Emerging growth company | Yes |
| 2022-11-07 | 10-Q | Emerging growth company | Yes |
| 2022-08-11 | 10-Q | Emerging growth company | Yes |
| 2022-05-09 | 10-Q | Emerging growth company | Yes |
| 2022-03-02 | 10-K | Emerging growth company | Yes |
| 2021-11-12 | 10-Q | Emerging growth company | Yes |
| 2021-08-10 | 10-Q | Emerging growth company | Yes |
| 2021-05-07 | 10-Q | Emerging growth company | Yes |
| 2021-03-17 | 10-K | Emerging growth company | Yes |
| 2020-11-09 | 10-Q | Emerging growth company | Yes |
| 2020-08-05 | 10-Q | Emerging growth company | Yes |
| 2020-05-07 | 10-Q | Emerging growth company | Yes |
| 2020-03-13 | 10-K | Emerging growth company | Yes |
| 2019-11-06 | 10-Q | Stock registered under Section 12(b) | Common Stock · VRCA · NASDAQ |
| 2019-11-06 | 10-Q | Emerging growth company | Yes |
| 2019-08-07 | 10-Q | Emerging growth company | Yes |
| 2019-05-07 | 10-Q | Emerging growth company | Yes |
| 2019-03-07 | 10-K | Emerging growth company | Yes |
| 2018-11-07 | 10-Q | Smaller reporting company | No |
| 2018-11-07 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |